Oct 16, 2019
In the first episode of a two-part series, join Chief Medical Oncologist at USA Mitchell Cancer Institute, Dr. Arthur Frankel, for a fascinating deep dive conversation into oncology and cancer therapies and find out what Immune Checkpoint Therapy is and what types of cancer it’s used in.
Dr. Arthur Frankel is the Chief Medical Oncologist at USA Mitchell Cancer Institute in Mobile, Alabama where he specializes in Hematology and Medical Oncology. He received his medical degree from Harvard Medical School with his residency and medical oncology fellowship at Stanford University.
Frankel is passionate about
helping oncologists and the community navigate the rapid advances
in cancer care. He says there is an “explosion of knowledge” that
comes with new treatments and his “goal is to advance the quality
of cancer care in his area. Having received over a dozen grants,
and participated in just as many clinical trials, he currently has
a pending grant for 5-year study on the "Role of Gut Microbiota in
Modulating Immune Checkpoint Inhibitor Therapy for Cancer." Frankel
has stated that immunotherapy is the most important advance in the
past decade against cancer. He understands and is passionate about
the connection between the immune system and the constantly
evolving nature of cancer and tumors.